Lowpa In Vivo Studies On Receptor Pharmacology

1. Low PA, Zimmerman BR, Dyck PJ. Comparison of distal sympathetic with vagal function in diabetic neuropathy. Muscle Nerve 1986;9:592-596.

2. Anonymous. Consensus statement on the definition of orthostatic hypotension, pure auto-nomic failure, and multiple system atrophy. The Consensus Committee of the American Autonomic Society and the American Academy of Neurology. Neurology 1996;46:1470.

3. Low PA, Denq JC, Opfer-Gehrking TL, Dyck PJ, O'Brien PC, Slezak JM. Effect of age and gender on sudomotor and cardiovagal function and blood pressure response to tilt in normal subjects. Muscle Nerve 1997;20:1561-1568.

4. Hoeldtke RD, Streeten DH. Treatment of orthostatic hypotension with erythropoietin. N Engl J Med 1993;329:611-615.

5. Korner PI, West MJ, Shaw J, Uther JB. "Steady-state" properties of the baroreceptor-heart rate reflex in essential hypertension in man. Clin Exp Pharmacol Physiol 1974;1:65-76.

6. Joyner MJ, Shepherd JT. Autonomic regulation of circulation, in Clinical Autonomic Disorders: Evaluation and Management (Low PA, ed.), Lippincott-Raven, Philadelphia, 1997, pp. 61-71.

7. Carvalho MJ, van Den Meiracker AH, Boomsma F, et al. Diurnal blood pressure variation in progressive autonomic failure. Hypertension 2000;35:892-897.

8. Rowell LB. Regulation of splanchnic blood flow in man. Physiologist 1973;16:127-142.

9. Thirlwell MP, Zsoter TT. The effect of propranolol and atropine on venomotor reflexes in man. Venous reflexes—effect of propranolol and atropine. J Med 1972;3:65-72.

10. Low PA, Walsh JC, Huang CY, McLeod JG. The sympathetic nervous system in alcoholic neuropathy. A clinical and pathological study. Brain 1975;98:357-364.

11. Novak V, Novak P, Spies JM, Low PA. Autoregulation of cerebral blood flow in orthostatic hypotension. Stroke 1998;29:104-111.

12. Depresseux JC, Rousseau JJ, Franck G. The autoregulation of cerebral blood flow, the cerebrovascular reactivity and their interaction in the Shy-Drager syndrome. Eur Neurol 1979;18:295-301.

13. Brooks DJ, Redmond S, Mathias CJ, Bannister R, Symon L. The effect of orthostatic hypotension on cerebral blood flow and middle cerebral artery velocity in autonomic failure, with observations on the action of ephedrine. J Neurol Neurosurg Psychiatry 1989;52:962-966.

14. Novak V, Gordon V, Novak P, LowPA. Altered cerebral autoregulation in patients with orthostatic hypotension. Neurology 1997;48:A131.

15. Rundles RW. Diabetic neuropathy. General review with report of 125 cases. Medicine 1945;24:111-160.

16. Veglio M, Carpano-Maglioli P, Tonda L, et al. Autonomic neuropathy in non-insulin-dependent diabetic patients: correlation with age, sex, duration and metabolic control of diabetes. Diabete Metab 1990;16:200-206.

17. Mulder DW, Lambert EH, Bastron JA, Sprague RG. The neuropathies associated with diabetes mellitus: a clinical and electromyographic study of 103 unselected diabetic patients. Neurology 1961;11:275-284.

18. Young RJ, Ewing DJ, Clarke BF. Nerve function and metabolic control in teenage diabetics. Diabetes 1983;32:142-147.

19. Palumbo PJ, Elveback LR, Whisnant JP. Neurologic complications of diabetes mellitus: transient ischemic attack, stroke, and peripheral neuropathy. AdvNeurol 1978;19:593-601.

20. Hilsted J, Parving HH, Christensen NJ, Benn J, Galbo H. Hemodynamics in diabetic orthostatic hypotension. J Clin Invest 1981;68:1427-1434.

21. Mancia G, Grassi G, Ferrari A, Zanchetti A. Reflex cardiovascular regulation in humans. J Cardiovasc Pharmacol 1985;7:S152-S159.

22. Fujimura J, Camilleri M, Low PA, Novak V, Novak P, Opfer-Gehrking TL. Effect of perturbations and a meal on superior mesenteric artery flow in patients with orthostatic hypotension. J Auton Nerv Syst 1997;67:15-23.

23. Kooner JS, Raimbach S, Watson L, Bannister R, Peart S, Mathias CJ. Relationship between splanchnic vasodilation and postprandial hypotension in patients with primary autonomic failure. J Hypertens Suppl 1989;7:S40-S41.

24. Purewal TS, Goss DE, Zanone MM, Edmonds ME, Watkins PJ. The splanchnic circulation and postural hypotension in diabetic autonomic neuropathy. Diabetes Med 1995;12:513-522.

25. Low PA, Opfer-Gehrking TL, McPhee BR. Prospective evaluation of clinical characteristics of orthostatic hypotension. Mayo Clin Proc 1995;70:617-622.

26. Robertson D, Kincaid DW, Robertson RM. The head and neck discomfort of autonomic failure: an unrecognized etiology of headache. Clin Auton Res 1994;4:99-103.

27. Schrezenmaier C, Gehrking JA, Hines SM, Low PA, Benrud-larson LM, Sandroni P. Evaluation of orthostatic hypotension: relationship of a new self-report instrument to laboratory-based measures. Mayo Clin Proc 2005;80:330-334.

28. Fealey RD, Low PA, Thomas JE. Thermoregulatory sweating abnormalities in diabetes mellitus. Mayo Clin Proc 1989;64:617-628.

29. Benarroch EE, Opfer-Gehrking TL, Low PA. Use of the photoplethysmographic technique to analyze the Valsalva maneuver in normal man. Muscle Nerve 1991;14:1165-1172.

30. Sandroni P, Benarroch EE, Low PA. Pharmacological dissection of components of the Valsalva maneuver in adrenergic failure. J Appl Physiol 1991;71:1563-1567.

31. Sandroni P, Novak V, Opfer-Gehrking TL, Huck CA, Low PA. Mechanisms of blood pressure alterations in response to the Valsalva maneuver in postural tachycardia syndrome. Clin Auton Res 2000;10:1-5.

32. Corbett JL, Frankel HL, Harris PJ. Cardiovascular changes associated with skeletal muscle spasm in tetraplegic man. J Physiol 1971;215:381-393.

33. Candel S, Ehrlich DE. Venous blood flow during the Valsalva experiment including some clinical applications. Am J Med 1953;15:307-315.

34. Brooker JZ, Alderman EL, Harrison DC. Alterations in left ventricular volumes induced by Valsalva manoeuvre. Br Heart J 1974;36:713-718.

35. Delius W, Hagbarth KE, Hongell A, Wallin BG. Manoeuvres affecting sympathetic outflow in human muscle nerves. Acta Physiol Scand 1972;84:82-94.

36. Wexler L, Bergel DH, Gabe IT, Makin GS, Mills CJ. Velocity of blood flow in normal human venae cavae. Circ Res 1968;23:349-359.

37. Low PA. Composite autonomic scoring scale for laboratory quantification of generalized autonomic failure. Mayo Clin Proc 1993;68:748-752.

38. Vogel ER, Sandroni P, Low PA. Blood pressure recovery from Valsalva maneuver in patients with autonomic failure. Neurology 2005;65:1517.

39. El-Sayed H, Hainsworth R. Salt supplementation increases plasma volume and orthostatic tolerance in patients with unexplained syncope. Heart 1996;75:134-140.

40. Jordan J, Shannon JR, Black BK, et al. The pressor response to water drinking in humans: a sympathetic reflex? Circulation 2000;101:504-509.

41. Denq JC, Opfer-Gehrking TL, Giuliani M, Felten J, Convertino VA, Low PA. Efficacy of compression of different capacitance beds in the amelioration of orthostatic hypotension. Clin Auton Res 1997;7:321-326.

42. Ten Harkel AD, van Lieshout JJ, Wieling W. Effects of leg muscle pumping and tensing on orthostatic arterial pressure: a study in normal subjects and patients with autonomic failure. Clin Sci 1994;87:553-558.

43. Bouvette CM, McPhee BR, Opfer-Gehrking TL, Low PA. Role of physical counterma-neuvers in the management of orthostatic hypotension: Efficacy and biofeedback augmentation. Mayo Clin Proc 1996;71:847-853.

44. Fealey RD, Robertson D. Management of orthostatic hypotension, in Clinical Autonomic Disorders: Evaluation and Management (Low PA, ed.), Lippincott-Raven, Philadelphia, 1997, pp. 763-775.

45. Low PA, Gilden JL, Freeman R, Sheng KN, McElligott MA. Efficacy of midodrine vs placebo in neurogenic orthostatic hypotension. A randomized, double-blind multicenter study. Midodrine Study Group. JAMA 1997;277:1046-1051.

46. Wright RA, Kaufmann HC, Perera R, et al. A double-blind, dose-response study of mido-drine in neurogenic orthostatic hypotension. Neurology 1998;51:120-124.

47. Singer W, Opfer-Gehrking TL, McPhee BR, Hilz MJ, Bharucha AE, Low PA. Acetylcholinesterase inhibition: a novel approach in the treatment of neurogenic orthostatic hypotension. J Neurol Neurosurg Psychiatry 2003;74:1294-1298.

48. Thompson CA, Tatro DL, Ludwig DA, Convertino VA. Baroreflex responses to acute changes in blood volume in humans. Am J Physiol 1990;259:R792-R798.

49. Perera R, Isola L, Kaufmann H. Effect of recombinant erythropoietin on anemia and orthostatic hypotension in primary autonomic failure. Clin Auton Res 1995;5:211-213.

50. Low PA, Opfer-Gehrking TL Kihara M. In vivo studies on receptor pharmacology of the human eccrine sweat gland. Clin Auton Res 1992;2:29-34.

51. Low PA, Caskey PE, Tuck RR, Fealey RD, Dyck PJ. Quantitative sudomotor axon reflex test in normal and neuropathic subjects. Ann Neurol 1983;14:573-580.

52. Low PA, Zimmerman IR. Development of an autonomic laboratory, in Clinical Autonomic Disorders: Evaluation and Management (Low PA, ed.), Little Brown and Company, Boston, 1993, pp. 345-354.

53. Stewart JD, Low PA, Fealey RD. Distal small fiber neuropathy: results of tests of sweating and autonomic cardiovascular reflexes. Muscle Nerve 1992;15:661-665.

54. Hoeldtke RD, Bryner KD, Horvath GG, Phares RW, Broy LF, Hobbs GR. Redistribution of sudomotor responses is an early sign of sympathetic dysfunction in type 1 diabetes. Diabetes 2001;50:436-443.

55. Chemali KR, Gorodeski R, Chelimsky TC. Alpha-adrenergic supersensitivity of the sudomotor nerve in complex regional pain syndrome. Ann Neurol 2001;49:453-459.

56. Fealey RD. Thermoregulatory sweat test, in Clinical Autonomic Disorders: Evaluation and Management (Low PA, ed.), Lippincott-Raven, Philadelphia, 1997, pp. 245-257.

57. Schondorf R. The role of sympathetic skin responses in the assessment of autonomic function, in Clinical Autonomic Disorders: Evaluation and Management (Low PA, ed.), Little, Brown and Company, Boston, 1993, pp. 231-241.

58. Shahani BT, Halperin JJ, Boulu P, Cohen J. Sympathetic skin response—a method of assessing unmyelinated axon dysfunction in peripheral neuropathies. J Neurol Neurosurg Psychiatry 1984;47:536-542.

59. Edelberg R. Electrical properties of the skin, in Methods in Psychophysiology (Brown CC, ed.), Williams and Wilkins, Baltimore, 1967, pp. 1-52.

60. Lloyd D. Action potential and secretory potential of sweat glands. Proc Natl Acad Sci USA 1961;47:351-362.

61. Morimoto T, Imai Y, Watari H. Skin potential response and sweat output of the cat foot pad. Jpn J Physiol 1974;24:205-215.

62. Richter CP. A study of the electrical skin resistance and the psychogalvanic reflex in a case of unilateral sweating. Brain 1927;50:216-235.

63. Shaver BA, Brusilow SW, Cooke RE. Origin of the galvanic skin response. Proc Soc Exp Biol Med 1962;110:559-564.

64. Levy DM, Reid G, Rowley DA, Abraham RR. Quantitative measures of sympathetic skin response in diabetes: relation to sudomotor and neurological function. J Neurol Neurosurg Psychiatry 1992;55:902-908.

65. Low PA. Quantitation of autonomic function, in Peripheral Neuropathy (Dyck, PJ, Thomas, PK, Lambert, EH, and Bunge, R, eds.), WB Saunders, Philadelphia, 1984, pp. 1139-1165.

66. Sourek K. The nervous control of skin potentials in man. Rozpravy Ceskoslovenske Akademie Ved Roenik 75-Sesit 1, Prague, 1965;1-97.

67. Arunodaya GR, Taly AB. Sympathetic skin response: a decade later. J Neurol Sci 1995; 129:81-89.

68. Tzeng SS, Wu ZA, Chu FL. The latencies of sympathetic skin responses. Eur Neurol 1993;33:65-68.

69. Maselli RA, Jaspan JB, Soliven BC, Green AJ, Spire JP, Arnason BGW. Comparison of sympathetic skin response with quantitative sudomotor axon reflex test in diabetic neuropathy. Muscle Nerve 1989;12:420-423.

70. Drory VE, Korczyn AD. Sympathetic skin response: age effect. Neurology 1993;43:1818-1820.

71. Knezevic W, Bajada S. Peripheral autonomic surface potential. A quantitative technique for recording sympathetic conduction in man. J Neurol Sci 1985;67:239-251.

72. Soliven B, Maselli R, Jaspan J, et al. Sympathetic skin response in diabetic neuropathy. Muscle Nerve 1987;10:711-716.

73. Braune HJ, Horter C. Sympathetic skin response in diabetic neuropathy: a prospective clinical and neurophysiological trial on 100 patients. J Neurol Sci 1996;138:120-124.

74. Niakan E, Harati Y. Sympathetic skin response in diabetic peripheral neuropathy. Muscle Nerve 1988;11:261-264.

75. Watkins PJ. Facial sweating after food: a new sign of diabetic autonomic neuropathy. Br Med J 1973;1:583-587.

76. Shaw JE, Parker R, Hollis S, Gokal R, Boulton AJ. Gustatory sweating in diabetes mellitus. Diabet Med 1996;13:1033-1037.

77. Kurchin A, Adar R, Zweig A, Mozes M. Gustatory phenomena after upper dorsal sympa-thectomy. Arch Neurol 1977;34:619-623.

78. Restivo DA, Lanza S, PattiF, et al. Improvement of diabetic autonomic gustatory sweating by botulinum toxin type A. Neurology 2002;59:1971-1973.

79. Atkin SL, Brown PM. Treatment of diabetic gustatory sweating with topical glycopyrro-late cream. Diabet Med 1996;13:493-494.

80. Shaw JE, Abbott CA, Tindle K, Hollis S, Boulton AJ. A randomised controlled trial of topical glycopyrrolate, the first specific treatment for diabetic gustatory sweating. Diabetologia 1997;40:299-301.

81. Glaister DH, Hearnshaw JR, Heffron PF, Peck AW. The mechanism of post-parotidectomy gustatory sweating (the auriculotemporal syndrome). Br Med J 1958;2:942-946.

82. Gardner WJ, McCubbin JW. Auriculotemporal syndrome: gustatory sweating due to misdirection of regenerated nerve fibers. JAMA 1956;160:272-277.

83. von Lindern JJ, Niederhagen B, Berge S, Hagler G, Reich RH. Frey syndrome: treatment with type A botulinum toxin. Cancer 2000;89:1659-1663.

84. Beerens AJ, Snow GB. Botulinum toxin A in the treatment of patients with Frey syndrome. Br J Surg 2002;89:116-119.

85. Drummond PD. Mechanism of gustatory flushing in Frey's syndrome. Clin Auton Res 2002; 12:144-146.

86. Periquet MI, Novak V, Collins MP, et al. Painful sensory neuropathy: prospective evaluation using skin biopsy. Neurology 1999;53:1641-1647.

87. Sandroni P, Davis MDP, Harper CM Jr, et al. Neurophysiologic and vascular studies in ery-thromelalgia: A retrospective analysis. J Clin Neuromusc Dis 1999;1:57-63.

88. Novak V, Freimer ML, Kissel JT, et al. Autonomic impairment in painful neuropathy. Neurology 2001;56:861-868.

89. Singer W, Spies JM, McArthur J, et al. Prospective evaluation of somatic and autonomic small fibers in selected autonomic neuropathies. Neurology 2004:62:612-618.

Diabetes 2

Diabetes 2

Diabetes is a disease that affects the way your body uses food. Normally, your body converts sugars, starches and other foods into a form of sugar called glucose. Your body uses glucose for fuel. The cells receive the glucose through the bloodstream. They then use insulin a hormone made by the pancreas to absorb the glucose, convert it into energy, and either use it or store it for later use. Learn more...

Get My Free Ebook

Post a comment